Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IDH1/2 Mutational Analysis in AML Patients: Diagnosis and Follow-up

NCT04242849 is registered in ClinicalTrials.gov with Josep Carreras Leukaemia Research Institute as lead sponsor.

NCT NCT04242849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04242849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IDH1/2 Mutational Analysis in AML Patients: Diagnosis and Follow-up
Lead sponsor
Josep Carreras Leukaemia Research Institute
Phase
Observational
Overall status
Completed
Start date
May 23, 2016
Completion date
January 16, 2020
Enrollment
354 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia